Skip to main content
Show — Main navigation
Hide — Main navigation
Home
About
The Chair
Inquiry Team
Expert Groups
Inquiry Intermediaries
Core Participants
Legal Representatives
Financial Reports
Approach
Terms of reference
List of Issues
Statements of approach
Inquiry Principles
News
News
Newsletter Archive
Reports
The Inquiry Report
Additional Compensation Report
First Interim Report
Second Interim Report
Compensation Framework Study
Evidence
Evidence
Hearings Archive
Compensation
Support
NHS Psychological Support
Confidential Psychological Support
Support Groups
Infected Blood Support Schemes
Treatment and aftercare
Medical Evidence
Expenses Guidance
Contact us
Search
Accessibility Tool
Zoom in
Zoom out
Reset
Contrast
Accessibility tool
Listen
Get in touch
Quick Exit
Subscribe to Search results
Search
Sort your search results
Relevance
Title
Changed
Dr Craske expressed concern that he did not know the outcome of patients who had received Factor VIII from batch HL3186 and other batches which might have contained HIV.
Published on:
26 July, 2024
Four blood donations by a donor who showed symptoms of AIDS were identified.
Published on:
26 July, 2024
Recall arrangements in respect of batch HL3186 were instituted in Cardiff.
Published on:
26 July, 2024
The Blood Products Laboratory requested a lookback in relation to some batches of Factor 8. Dr Jayaswal, consultant haematologist at Wessex RTC, advised "Logistically it is going to be impossible for us to scrutinize 1500 donors from so long ago".
Published on:
26 July, 2024
Dr Lane of the Blood Products Laboratory chased a lookback exercise involving Wessex RTC and highlighted that the Factor 8 batches related to a potential HIV seroconversion in a young person with haemophilia.
Published on:
26 July, 2024
Dr Smith agreed to check the records at Wessex RTC to see if any HIV 1 antibody positive donors were implicated in batch 8CRV1526.
Published on:
26 July, 2024
Dr Gunson reported to a meeting of the regional transfusion directors on the plan to be adopted when a patient was diagnosed with AIDS and had donated or received blood or blood products.
Published on:
26 July, 2024
The terms of reference for the Advisory Committee on the National Blood Transfusion Service Working Group on AIDS were "To consider the implications for the National Blood Transfusion Service of testing blood donations for antibody to HTLV III and to report."
Published on:
26 July, 2024
During a meeting of regional transfusion directors it was noted that when tracing the recipients of donations from a HIV-positive donor, finding that a recipient had died was "not necessarily the end of the story" as the recipient's organs may have been used for transplantation.
Published on:
26 July, 2024
The working party of the Regional Transfusion Directors' Committee produced a report on the screening of blood donations for anti-HTLV-3 in regional blood transfusion centres. Procedures for testing donations were set out in full as well as the follow-up for HTLV-3 positive donations.
Published on:
26 July, 2024
It was agreed at a meeting of the Expert Advisory Group on AIDS sub-group that where long-standing donors were found to be antibody positive, only physicians should be informed (via the haematologist). It would be for the physician to decide further action. This line would be presented to the Expert Advisory Group on AIDS.
Published on:
26 July, 2024
A retrospective study of HIV infection associated with unheated NHS Factor 8 and 9 was produced.
Published on:
26 July, 2024
Dr Terence Snape produced a report on the recall of Factor 8 batch HL3186 occasioned by probable diagnosis of AIDS in a contributing donor.
Published on:
26 July, 2024
The meeting of the Expert Advisory Group on AIDS was briefed that funding proposals had been submitted for an extra 1,500 places on counselling courses at St Mary's, Birmingham and Manchester in the next financial year.
Published on:
26 July, 2024
The Expert Advisory Group on AIDS Screening Test Sub-Group met. The meeting focused on issues of testing and consent. It was noted that all individuals with positive results "must be told because of the dangers to their health and that of others".
Published on:
26 July, 2024
At a meeting of the regional transfusion directors meeting it was anticipated that a DHSS working group might be set up to consider the legal implications of the advice of the Medical Defence Union.
Published on:
26 July, 2024
A letter was sent by Dr Michael Barnes, Deputy Medical Director of the Wessex Regional Transfusion Centre, to the haemophilia centre directors in the Wessex region to recall unused Factor 8 from batch HL3186.
Published on:
26 July, 2024
Dr Barnes wrote to all directors of haemophilia centres in Wessex re-emphasising his request for information to be kept quiet.
Published on:
26 July, 2024
At the first meeting of the Advisory Committee on the National Blood Transfusion Service Working Group it was agreed that donors should be told that their donations would be tested for HTLV-3, and that those whose donations tested positive should be informed, but there was no unanimity on how to do this.
Published on:
26 July, 2024
A paper was produced by the Expert Advisory Group on AIDS Screening Sub-Committee: "Follow Up of Blood Donations Previously Given by Donors who are Identified as Positive for HTLV III Antibody".
Published on:
26 July, 2024
Pagination
First page
First
Previous page
Previous
…
Page
2094
Page
2095
Page
2096
Page
2097
Current page
2098
Page
2099
Page
2100
Page
2101
Page
2102
…
Next page
Next
Last page
Last